Association between insulin-like growth factor-1 and cardiovascular events: a systematic review and dose–response meta-analysis of cohort studies

[1] Roth GA(2020)Global burden of cardiovascular diseases and risk factors, 1990–2019: update from the GBD 2019 study J Am Coll Cardiol 76 2982-3021

[2] Mensah GA(1978)The amino acid sequence of human insulin-like growth factor I and its structural homology with proinsulin J Biol Chem 253 2769-2776

[3] Johnson CO(1981)Somatomedin-C mediates growth hormone negative feedback by effects on both the hypothalamus and the pituitary Science 212 1279-1281

[4] Rinderknecht E(2016)Attenuated IGF-1 predicts all-cause and cardiovascular mortality in a black population: a five-year prospective study Eur J Prev Cardiol 23 1690-1699

[5] Humbel RE(2016)Biomarkers of cardiovascular disease and mortality risk in patients with advanced CKD Clin J Am Soc Nephrol 11 1163-1172

[6] Berelowitz M(2021)Echocardiographic findings in acromegaly: prevalence of concentric left ventricular remodeling in a large single-center cohort J Endocrinol Invest 44 2665-2674

[7] Szabo M(2021)Electrophysiological features in acromegaly: re-thinking the arrhythmic risk? J Endocrinol Invest 44 209-221

[8] Frohman LA(2003)Serum insulin-like growth factor I and risk for heart failure in elderly individuals without a previous myocardial infarction: the Framingham heart study Ann Intern Med 139 642-648

[9] Firestone S(2004)Insulin-like growth factor-I gene polymorphism and risk of heart failure (the Rotterdam study) Am J Cardiol 94 384-386

[10] Chu L(2010)The association of serum insulin-like growth factor-I with mortality, cardiovascular disease, and cancer in the elderly: a population-based study J Clin Endocrinol Metab 95 4616-4624

[1] Roth GA(2020)Global burden of cardiovascular diseases and risk factors, 1990–2019: update from the GBD 2019 study J Am Coll Cardiol 76 2982-3021

[2] Mensah GA(1978)The amino acid sequence of human insulin-like growth factor I and its structural homology with proinsulin J Biol Chem 253 2769-2776

[3] Johnson CO(1981)Somatomedin-C mediates growth hormone negative feedback by effects on both the hypothalamus and the pituitary Science 212 1279-1281

[4] Rinderknecht E(2016)Attenuated IGF-1 predicts all-cause and cardiovascular mortality in a black population: a five-year prospective study Eur J Prev Cardiol 23 1690-1699

[5] Humbel RE(2016)Biomarkers of cardiovascular disease and mortality risk in patients with advanced CKD Clin J Am Soc Nephrol 11 1163-1172

[6] Berelowitz M(2021)Echocardiographic findings in acromegaly: prevalence of concentric left ventricular remodeling in a large single-center cohort J Endocrinol Invest 44 2665-2674

[7] Szabo M(2021)Electrophysiological features in acromegaly: re-thinking the arrhythmic risk? J Endocrinol Invest 44 209-221

[8] Frohman LA(2003)Serum insulin-like growth factor I and risk for heart failure in elderly individuals without a previous myocardial infarction: the Framingham heart study Ann Intern Med 139 642-648

[9] Firestone S(2004)Insulin-like growth factor-I gene polymorphism and risk of heart failure (the Rotterdam study) Am J Cardiol 94 384-386

[10] Chu L(2010)The association of serum insulin-like growth factor-I with mortality, cardiovascular disease, and cancer in the elderly: a population-based study J Clin Endocrinol Metab 95 4616-4624